Funding for this research was provided by:
Japan Society for the Promotion of Science (18K17369, 20K10546)
National Center for Global Health and Medicine (20A05)
Japan Agency for Medical Research and Development (JP20fk0108502)
Ministry of Health, Labour and Welfare (Research for risk assessment, implementation of crisis management functions for emerging, re-emerging infectious diseases)
Received: 28 September 2021
Accepted: 8 August 2022
First Online: 19 August 2022
: This study was reviewed and approved by the Ethics Committee of the Center Hospital of the NCGM (NCGM-G-004121-00).
: According to local ethical guidelines, responses to questionnaire were regarded as participant consent.
: PB reports grants from Pfizer, GlaxoSmithKline, and the European Commission IMI, unrelated to this work.